Gan & Lee Pharmaceuticals Presents Two Positive Clinical Results for Once-Weekly Insulin GZR4 at 60th European Association for the Study of Diabetes Annual Meeting (EASD 2024)
In Phase Ia clinical trials, GZR4 demonstrated a favorable safety and tolerability…
